From: Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer
Css (μg/ml)
Time to ss(h)
Acc T1/2 (h)
Cl (L/h)
1
0.92
0.67
0.13
1.08
2
0.65
1.00
0.20
1.53
4
0.77
1.28
5
0.66
1.51
6
0.96
1.03
Mean ± SD
0.79 ± 0.14
0.87 ± 0.18
0.17 ± 0.04
1.29 ± 0.23